Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Incyte
Pharma
Incyte secures anal cancer nods years after FDA rejection
Incyte's Zynyz has become the first treatment specifically approved by the FDA in first-line anal cancer.
Angus Liu
May 16, 2025 10:10am
Incyte, Novartis reach settlement in Jakafi royalty dispute
May 6, 2025 10:15am
Congress's biotech report, NIH ban, GSK-ABL—Fierce Pharma Asia
Apr 11, 2025 10:31am
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
Apr 10, 2025 10:00am
Incyte posts mixed Opzelura results in prurigo nodularis
Mar 10, 2025 11:23am
Incyte provides first guidance for JAK cream Opzelura
Feb 10, 2025 2:25pm
